Skip to content

Raltegravir shows potential for use as PrEP drug

Cosmetic treatment for facial fat loss safe and effective in the long term

South Africa faces treatment funding shortfall

Rheumatologic symptoms after ART may be due to immune reconstitution inflammatory syndrome (IRIS)

Starting HIV therapy improves some cardiovascular markers - but not all

GSK and Pfizer HIV divisions to form new company

Significant reductions in price of first- and second-line HIV treatment thanks to UNITAID and Clinton deal

Bone loss during HIV treatment most associated with protease inhibitors

Higher rates of breast enlargement in men in South Africa on ART